Guide to Asthma Management | Pharmacy QI | May 2021
May 2021 | Practical Tips for Quality Improvement | View PDF
- Treatment of asthma with SABA alone is no longer recommended.
- For mild asthma, treatment with as-needed ICS-formoterol reduces the risk of severe
exacerbations by about two-thirds compared to treatment with SABA only.
- Treatment with regular daily low-dose ICS, with as-needed SABA, is highly effective in
reducing asthma symptoms and exacerbations, hospitalizations, and death.
- Step-down treatment once good asthma control has been achieved and maintained for three months.
- If resident has persistent, uncontrolled symptoms despite two to three months of controller treatment, assess for:
• Incorrect inhaler technique
• Poor adherence
• Persistent exposure to triggers (e.g., allergens, tobacco smoke, medications such as beta-blockers or NSAIDs)
• Comorbidities that may contribute to respiratory symptoms and poor quality of life
• Incorrect diagnosis
- Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. 2020 Update. https://ginasthma.org/wp-content/uploads/2020/04/GINA-2020-full-report_-final-_wms.pdf. Accessed March 28, 2021.
- Yang CL, Hicks EA, Mitchell P, et al. 2021 Canadian Thoracic Society Guideline – A focused update of the management of very mild and mild asthma. Can J Resp, Critical Care, and Sleep Med. https://cts-sct.ca/wp-content/uploads/2021/02/FINAL-CTS_Very-Mild-and-Mild-Asthma-CPG.pdf. Accessed March 28, 2021.